Literature DB >> 22654428

Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation.

Hiroya Iida1, Tsukasa Aihara, Shinichi Ikuta, Hidenori Yoshie, Naoki Yamanaka.   

Abstract

AIM: To compare the effect of percutaneous transhepatic portal vein embolization (PTPE) and unilateral portal vein ligation (PVL) on hepatic hemodynamics and right hepatic lobe (RHL) atrophy.
METHODS: Between March 2005 and March 2009, 13 cases were selected for PTPE (n = 9) and PVL (n = 4) in the RHL. The PTPE group included hilar bile duct carcinoma (n = 2), intrahepatic cholangiocarcinoma (n = 2), hepatocellular carcinoma (n = 2) and liver metastasis (n = 3). The PVL group included hepatocellular carcinoma (n = 2) and liver metastasis (n = 2). In addition, observation of postoperative hepatic hemodynamics obtained from computed tomography and Doppler ultrasonography was compared between the two groups.
RESULTS: Mean ages in the two groups were 58.9 ± 2.9 years (PVL group) vs 69.7 ± 3.2 years (PTPE group), which was a significant difference (P = 0.0002). Among the indicators of liver function, including serum albumin, serum bilirubin, aspartate aminotransferase, alanine aminotransferase, platelets and indocyanine green retention rate at 15 min, no significant differences were observed between the two groups. Preoperative RHL volumes in the PTPE and PVL groups were estimated to be 804.9 ± 181.1 mL and 813.3 ± 129.7 mL, respectively, with volume rates of 68.9% ± 2.8% and 69.2% ± 4.2%, respectively. There were no significant differences in RHL volumes (P = 0.83) and RHL volume rates (P = 0.94), respectively. At 1 mo after PTPE or PVL, postoperative RHL volumes in the PTPE and PVL groups were estimated to be 638.4 ± 153.6 mL and 749.8 ± 121.9 mL, respectively, with no significant difference (P = 0.14). Postoperative RHL volume rates in the PTPE and PVL groups were estimated to be 54.6% ± 4.2% and 63.7% ± 3.9%, respectively, which was a significant difference (P = 0.0056). At 1 mo after the operation, the liver volume atrophy rate was 14.3% ± 2.3% in the PTPE group and 5.4% ± 1.6% in the PVL group, which was a significant difference (P = 0.0061).
CONCLUSION: PTPE is a more effective procedure than PVL because PTPE is able to occlude completely the portal branch throughout the right peripheral vein.

Entities:  

Keywords:  Future liver remnant; Liver atrophy; Percutaneous transhepatic portal vein embolization; Portal vein ligation; Two-stage hepatectomy

Mesh:

Year:  2012        PMID: 22654428      PMCID: PMC3353371          DOI: 10.3748/wjg.v18.i19.2371

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function.

Authors:  H Tanaka; K Hirohashi; S Kubo; T Shuto; I Higaki; H Kinoshita
Journal:  Br J Surg       Date:  2000-07       Impact factor: 6.939

2.  Two-stage hepatectomy for multiple bilobular liver metastases from colorectal cancer.

Authors:  Shinji Togo; Yasuhiko Nagano; Hidenobu Masui; Kuniya Tanaka; Yasuhiko Miura; Daisuke Morioka; Itaru Endo; Hitoshi Sekido; Hideyuki Ike; Hiroshi Shimada
Journal:  Hepatogastroenterology       Date:  2005 May-Jun

Review 3.  Present status and future perspectives of preoperative portal vein embolization.

Authors:  Hai Liu; Shaihong Zhu
Journal:  Am J Surg       Date:  2009-02-27       Impact factor: 2.565

4.  Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization.

Authors:  N Kokudo; K Tada; M Seki; H Ohta; K Azekura; M Ueno; K Ohta; T Yamaguchi; T Matsubara; T Takahashi; T Nakajima; T Muto; T Ikari; A Yanagisawa; Y Kato
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

5.  Two-stage liver surgery for advanced liver metastasis synchronous with colorectal tumor.

Authors:  N J Lygidakis; Gurusharan Singh; E Bardaxoglou; G Dedemadi; G Sgourakis; J Nestoridis; A Malliotakis; M Pedonomou; E K Solomou; M Safioleas; Maria Alamani; L Grigorakos; E M Merikas
Journal:  Hepatogastroenterology       Date:  2004 Mar-Apr

6.  Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor?

Authors:  L Mueller; C Hillert; L Möller; G Krupski-Berdien; X Rogiers; D C Broering
Journal:  Ann Surg Oncol       Date:  2008-05-06       Impact factor: 5.344

7.  Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function.

Authors:  E Okamoto; A Kyo; N Yamanaka; N Tanaka; K Kuwata
Journal:  Surgery       Date:  1984-05       Impact factor: 3.982

8.  Improved hepatocyte function of future liver remnant of cirrhotic rats after portal vein ligation: a bonus other than volume shifting.

Authors:  Kun-Ju Lin; Chien-Hung Liao; Ing-Tsung Hsiao; Tzu-Chen Yen; Tse-Ching Chen; Yi-Yin Jan; Miin-Fu Chen; Ta-Sen Yeh
Journal:  Surgery       Date:  2009-02       Impact factor: 3.982

9.  Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival.

Authors:  Martin Palavecino; Yun S Chun; David C Madoff; Daria Zorzi; Yoji Kishi; Ahmed O Kaseb; Steven A Curley; Eddie K Abdalla; Jean-Nicolas Vauthey
Journal:  Surgery       Date:  2009-04       Impact factor: 3.982

10.  Two-stage hepatectomy (R0) with portal vein ligation--towards curing patients with extended bilobular colorectal liver metastases.

Authors:  K Homayounfar; T Liersch; G Schuetze; M Niessner; A Goralczyk; J Meller; C Langer; B M Ghadimi; H Becker; T Lorf
Journal:  Int J Colorectal Dis       Date:  2008-12-16       Impact factor: 2.571

View more
  4 in total

1.  Bismuth classification is associated with the requirement for multiple biliary drainage in preoperative patients with malignant perihilar biliary stricture.

Authors:  Shin Miura; Atsushi Kanno; Atsushi Masamune; Shin Hamada; Tetsuya Takikawa; Eriko Nakano; Naoki Yoshida; Seiji Hongo; Kazuhiro Kikuta; Kiyoshi Kume; Morihisa Hirota; Hiroshi Yoshida; Yu Katayose; Michiaki Uuno; Tooru Shimosegawa
Journal:  Surg Endosc       Date:  2014-10-03       Impact factor: 4.584

2.  Tumour growth of colorectal rat liver metastases is inhibited by hepatic arterial infusion of the mTOR-inhibitor temsirolimus after portal branch ligation.

Authors:  Jens Sperling; Christian Ziemann; Anika Gittler; Anna Benz-Weißer; Michael D Menger; Otto Kollmar
Journal:  Clin Exp Metastasis       Date:  2015-02-19       Impact factor: 5.150

Review 3.  Portal vein embolization in extended liver resection.

Authors:  Nisha Narula; Thomas A Aloia
Journal:  Langenbecks Arch Surg       Date:  2017-05-31       Impact factor: 3.445

4.  Is there new hope for patients with marginally resectable liver malignancies.

Authors:  Martin Loos; Helmut Friess
Journal:  World J Gastrointest Surg       Date:  2012-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.